This content is machine translated Type 2 diabetes Smoking causes more than double the risk The characteristics of type 2 diabetes vary from patient to patient and the disease is thought to consist of four subtypes. However, a new study shows that smoking significantly increases...…
View Post 3 min This content is machine translated SGLT2 inhibitors and glucocorticoids Protective effect on kidney function is maintained SGLT2 inhibitors have been shown in randomized trials to be effective in improving cardiovascular and renal outcomes. However, the populations in these studies were carefully selected, usually excluding patients under...…
View Post 6 min This content is machine translated Cardiovascular risk Bad news for young men with T2D Cardiovascular disease ( CVD) remains the leading cause of death and disease worldwide, and people with type 1 or type 2 diabetes are at higher risk than the general population....…
View Post 5 min This content is machine translated Antithymocyte globulin in children with T1D Old medicine, new hope The well-known immunomodulatory drug antithymocyte globulin (ATG) can effectively inhibit the progression of type 1 diabetes (T1D) in young patients at low doses, while at the same time having a...…
View Post 3 min This content is machine translated Development of a quintuple agonist New strategy in the fight against obesity and T2D The treatment of obesity and type 2 diabetes is increasingly shifting to newer incretin drugs, including GLP1 receptor agonists (single agonists such as semaglutide) and GIP- and GLP1-RA (dual agonists...…
View Post 3 min This content is machine translated Adherence of GLP1-RA Half of patients discontinue treatment within a year GLP1 receptor agonists have revolutionized the treatment of obesity, but their effectiveness depends on long-term and continuous use. However, data from Danish health registries presented at EASD 2025 show that...…
